Folgen
Luigi R. Codecasa
Luigi R. Codecasa
Responsabile Centro Regionale Riferimento TBC, Ist. Villa Marelli, Osp. Niguarda
Bestätigte E-Mail-Adresse bei ospedaleniguarda.it
Titel
Zitiert von
Zitiert von
Jahr
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ...
European Respiratory Journal 56 (1), 2020
4902020
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
LC Christoph Lange, Ibrahim Abubakar, Jan-Willem C
european respiratory journal, 2014
4252014
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study
SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ...
European Respiratory Journal 49 (5), 2017
3672017
Clinical and operational value of the extensively drug-resistant tuberculosis definition
GB Migliori, G Besozzi, E Girardi, K Kliiman, C Lange, OS Toungoussova, ...
European Respiratory Journal 30 (4), 623-626, 2007
2792007
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open …
DE Griffith, G Eagle, R Thomson, TR Aksamit, N Hasegawa, K Morimoto, ...
American journal of respiratory and critical care medicine 198 (12), 1559-1569, 2018
2752018
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
American journal of respiratory and critical care medicine 190 (10), 1168-76, 2014
2722014
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy
M Losi, A Bossink, L Codecasa, C Jafari, M Ernst, S Thijsen, D Cirillo, ...
European Respiratory Journal 30 (6), 1173-1179, 2007
2432007
Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis
A Bandera, A Gori, L Catozzi, AD Esposti, G Marchetti, C Molteni, ...
Journal of clinical microbiology 39 (6), 2213-2218, 2001
2362001
Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020
GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ...
Emerging infectious diseases 26 (11), 2709, 2020
2272020
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ...
European Respiratory Journal 54 (6), 2019
1872019
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.
GB Migliori, C Lange, R Centis, et al
Eur Respir J 31 (6), 1155-59, 2008
1872008
Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients
F Piana, LR Codecasa, P Cavallerio, M Ferrarese, GB Migliori, ...
European Respiratory Journal 28 (1), 31-34, 2006
1752006
First evaluation of QuantiFERON-TB Gold Plus performance in contact screening
L Barcellini, E Borroni, J Brown, E Brunetti, D Campisi, PF Castellotti, ...
European respiratory journal 48 (5), 1411-1419, 2016
1702016
Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis
L Norbis, R Alagna, E Tortoli, LR Codecasa, GB Migliori, DM Cirillo
Expert review of anti-infective therapy 12 (5), 633-647, 2014
1602014
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
et al Giovanni Battista Migliori, Pei Min Thong, Jan-Willem Alffenaar ...
Eur Respir J, 2021
1512021
Risk assessment of tuberculosis in contacts by IFN-γ release assays. A Tuberculosis Network European Trials Group study
JP Zellweger, G Sotgiu, M Block, S Dore, N Altet, R Blunschi, M Bogyi, ...
American journal of respiratory and critical care medicine 191 (10), 1176-1184, 2015
1412015
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
GB Migliori, FM Marx, N Ambrosino, E Zampogna, HS Schaaf, ...
The International Journal of Tuberculosis and Lung Disease 25 (10), 797-813, 2021
1352021
Tuberculosis and COVID-19 co-infection: description of the global cohort
TB/COVID-19 Global Study Group
European Respiratory Journal 59 (3), 2022
1282022
First independent evaluation of QuantiFERON-TB Plus performance
L Barcellini, E Borroni, J Brown, E Brunetti, L Codecasa, F Cugnata, ...
European Respiratory Journal 47 (5), 1587-1590, 2016
1232016
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use
S Esposito, L D’Ambrosio, M Tadolini, HS Schaaf, JC Luna, B Marais, ...
European Respiratory Journal 44 (3), 811-815, 2014
1202014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20